Balhara, J., Shan, L., Zhang, J., Muhuri, A., Halayko, A. J., Almiski, M. S., . . . Gounni, A. S. (2017). Pentraxin 3 deletion aggravates allergic inflammation through a T(H)17-dominant phenotype and enhanced CD4 T-cell survival. J Allergy Clin Immunol.
استشهاد بنمط شيكاغوBalhara, Jyoti, et al. "Pentraxin 3 Deletion Aggravates Allergic Inflammation Through a T(H)17-dominant Phenotype and Enhanced CD4 T-cell Survival." J Allergy Clin Immunol 2017.
MLA استشهادBalhara, Jyoti, et al. "Pentraxin 3 Deletion Aggravates Allergic Inflammation Through a T(H)17-dominant Phenotype and Enhanced CD4 T-cell Survival." J Allergy Clin Immunol 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.